Literature DB >> 9024086

Angiogenin plasma levels during pregnancy.

M Kolben1, J Bläser, K Ulm, M Schmitt, K T Schneider, H Tschesche, H Graeff.   

Abstract

OBJECTIVE: Our purpose was to determine the levels in plasma of angiogenin in healthy pregnant women and to examine whether there are differences between uncomplicated pregnancies and patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets, preeclampsia-eclampsia, and highly pathologic Doppler flow findings without additional complications. STUDY
DESIGN: Angiogenin was measured with a novel enzyme-linked immunosorbent assay. A case control and observational study was conducted in 68 healthy women from the tenth to fortieth weeks of pregnancy and in 18 patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets, 21 with preeclampsia/eclampsia and 13 with highly pathologic Doppler flow findings at admission for delivery.
RESULTS: Between the tenth and fortieth weeks of uncomplicated pregnancy angiogenin plasma levels rose from 150 to 250 ng/ml (significant correlation). In patients with highly pathologic Doppler flow findings angiogenin is significantly reduced compared with healthy pregnant matched pairs (150 vs 219 ng/ml, p < 0.01).
CONCLUSION: Rising plasma angiogenin levels in pregnancy may reflect persisting placental transformation and remodeling processes: in patients with highly pathologic Doppler flow findings these processes are disturbed and thus placental function is impaired.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024086     DOI: 10.1016/s0002-9378(97)80008-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

2.  Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients.

Authors:  Ales Rozman; Mira Silar; Mitja Kosnik
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

Review 3.  The Potential of Angiogenin as a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis.

Authors:  Dongdong Yu; Yikai Cai; Wei Zhou; Jinghao Sheng; Zhengping Xu
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

4.  Role of circulating angiogenin levels in portal hypertension and TIPS.

Authors:  Alexander Queck; Frank E Uschner; Philip G Ferstl; Martin Schulz; Maximilian J Brol; Michael Praktiknjo; Robert Schierwagen; Sabine Klein; Christian P Strassburg; Carsten Meyer; Christian Jansen; Marie-Luise Berres; Jonel Trebicka
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.